Global Neurodiagnostics Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Technology;

Neuroimaging Technologies, In Vitro Diagnostics, and Neuro informatics.

By End Use;

Hospitals and Clinics.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn912124437 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Neurodiagnostics Market (USD Million), 2021 - 2031

In the year 2024, the Global Neurodiagnostics Market was valued at USD 7,922.53 million. The size of this market is expected to increase to USD 13,316.00 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.7%.

The global neurodiagnostics market has witnessed significant growth in recent years, driven by rising neurological disorders and the need for early, precise diagnosis. Neurodiagnostic tools and techniques, including imaging systems, electroencephalography (EEG), magnetoencephalography (MEG), and neuroinformatics, are crucial in detecting, monitoring, and treating neurological conditions such as Alzheimer’s disease, Parkinson’s disease, epilepsy, and brain injuries. With advancements in technology, these tools have become more accurate and accessible, facilitating the development of new diagnostic methods and contributing to the market's growth. Factors such as the aging population, increased healthcare spending, and growing awareness of neurological disorders further fuel this expansion.

One of the major drivers in the neurodiagnostics market is the rise in technological innovation, particularly in imaging systems like MRI and CT scans. These systems provide high-resolution, detailed images that help clinicians understand complex neurological structures and diagnose various brain-related disorders more effectively. Additionally, non-invasive techniques like EEG and MEG have advanced significantly, allowing for safer and quicker diagnostics. The integration of artificial intelligence and machine learning in neurodiagnostic technologies is also revolutionizing the market, as these technologies enhance diagnostic accuracy, predict potential health risks, and allow for personalized treatment plans. This innovation is increasingly being adopted by healthcare providers worldwide, contributing to the market's steady growth.

Despite the growth potential, the neurodiagnostics market faces several challenges, including high costs of advanced diagnostic equipment and limited access in developing regions. Additionally, a shortage of skilled professionals to operate sophisticated diagnostic machinery remains a barrier, especially in low-income areas where healthcare resources are constrained. Nonetheless, many companies and governments are investing in training initiatives and improving healthcare infrastructure to address these challenges. The global neurodiagnostics market is anticipated to continue expanding as it adapts to these obstacles, benefiting from increased research funding and strategic partnerships between healthcare institutions and technology providers. As the demand for effective diagnostic solutions rises, the neurodiagnostics market is positioned to play a vital role in addressing the global burden of neurological disorders.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Technology
    2. Market Snapshot, By End Use
    3. Market Snapshot, By Region
  4. Global Neurodiagnostics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Neurological Disorders
        2. Advancements in Imaging and Non-Invasive Techniques
        3. Growing Aging Population
      2. Restraints
        1. High Cost of Advanced Diagnostic Equipment
        2. Lack of Skilled Professionals
        3. Limited Access in Developing Region
      3. Opportunities
        1. Expansion in Emerging Markets
        2. Integration of AI and Machine Learning
        3. Development of Portable and Wearable Devices
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Neurodiagnostics Market, By Technology, 2021 - 2031 (USD Million)
      1. Neuroimaging Technologies
      2. In Vitro Diagnostics
      3. Neuro informatics
    2. Global Neurodiagnostics Market, ByEnd Use, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Clinics
    3. Global Neurodiagnostics Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Canon Medical Systems Corporation
      2. Siemens Healthineers AG
      3. Koninklijke Philips N.V.
      4. Thermo Fisher Scientific, Inc.
      5. FUJIFILM Corporation
      6. Natus Medical Incorporated (Natus)
      7. Lifelines Neuro
      8. Advanced Brain Monitoring, Inc.
      9. NIHON KOHDEN CORPORATION.
      10. F. Hoffmann-La Roche Ltd
      11. GE HealthCare.
      12. Mitsar Co. LTD.
  7. Analyst Views
  8. Future Outlook of the Market